Oh et al. described that an increased plasma leptin and leptin/adiponectin ratio was significantly associated with change in percent emphysema over three years, proposing a potential role as a biomarker in emphysema progression in patients with COPD [94]. Here, LEP is linked to pulmonary emphysema.